Disney June 2025 layoffs, targeting TV and film executives, signal cost-saving moves but risk eroding creative talent.

BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.

BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.

Impossible -- The Final Reckoning" gave China's box office a notable boost over the Duanwu Festival holiday, leading the ...

The Walt Disney Co. is laying off several hundred employees worldwide as the entertainment giant looks to trim some costs and ...

Vetcon HVAC & Plumbing of Orlando, a Veteran-Owned Company, is proud to announce the expansion of its commercial retrofit ...

China's factory activity in May shrank for the first time in eight months, a private-sector survey showed on Tuesday, ...

A two-year-old in the Western Division is Fiji’s youngest known Type 1 diabetes case. This has been revealed by Diabetes Fiji ...

The Grace Road Group is likely to expand its business operations in Nauru. This follows a meeting between the President of ...